Stockreport

DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia [Yahoo! Finance]

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report
PDF DM199 Preeclampsia program featured in recent National Public Radio (NPR) coverage MINNEAPOLIS, March 05, 2026 BUSINESS WIRE )--DiaMedica Therapeutics Inc. (Nasdaq: D [Read more]